Welcome to learn about our company
Leave Your Message
Welcome to learn about our company
Our featured plant extracts are standardized for cardiovascular and antioxidant support — ideal for heart-health supplement formulations worldwide.
Marigold extract, derived from the petals of Calendula officinalis, has emerged as one of the most scientifically promising botanical ingredients in cardiovascular supplement formulations. Traditionally revered for its anti-inflammatory and wound-healing properties, modern phytochemistry has revealed a rich matrix of bioactive compounds — primarily lutein, zeaxanthin, flavonoids (quercetin, isorhamnetin), saponins, and polyphenols — that collectively exert measurable cardioprotective effects.
Cardiovascular disease (CVD) remains the world's leading cause of mortality. As consumers increasingly seek preventive, natural-based solutions, marigold extract has captured the attention of nutraceutical formulators, clinical researchers, and supplement manufacturers alike. Its dual role as both an antioxidant powerhouse and an anti-inflammatory agent positions it uniquely at the intersection of eye health and cardiovascular wellness.
Lutein and zeaxanthin — the dominant carotenoids in marigold — are well-documented for reducing oxidative stress in endothelial cells, inhibiting LDL oxidation, and modulating inflammatory cytokine pathways that underlie atherosclerosis. Recent clinical studies further suggest these carotenoids may contribute to improved arterial elasticity and reduced intima-media thickness (IMT), key biomarkers of cardiovascular risk.
Each phytochemical in marigold extract targets a specific pathway in cardiovascular pathophysiology, offering multi-modal protection.
Inhibits LDL oxidation and macrophage foam cell formation — a primary driver of atherosclerotic plaque. Clinical data shows lutein supplementation (≥10 mg/day) significantly reduces carotid IMT in at-risk populations.
Flavonoids that suppress NF-κB inflammatory signaling, reduce C-reactive protein (CRP), and improve endothelial nitric oxide (eNOS) bioavailability — directly supporting vasodilation and healthy blood pressure.
Oleanolic acid and ursolic acid derivatives exhibit anti-thrombotic properties and help regulate lipid metabolism, reducing triglyceride accumulation and supporting HDL cholesterol balance.
The commercial trajectory for marigold extract in cardiovascular supplements is being shaped by converging forces across science, regulation, and consumer behavior.
The global cardiovascular nutraceuticals market exceeded USD 12.4 billion in 2023 and is projected to reach USD 22 billion by 2032 (CAGR ~6.8%). Within this, botanical extracts — particularly those with dual antioxidant and anti-inflammatory profiles like marigold — are among the fastest-growing subcategories. North America and Europe lead in premium supplement consumption, while Asia-Pacific is the fastest-expanding market, driven by rising middle-class health awareness in China, India, and Southeast Asia.
Post-pandemic consumer preferences have accelerated the "clean label" movement. Supplement buyers now actively seek plant-derived, non-GMO, allergen-free ingredients. Marigold extract — naturally sourced, organically cultivatable, and free from synthetic additives — aligns perfectly with this trend. Brands are increasingly replacing synthetic astaxanthin or beta-carotene with marigold-derived lutein in cardiovascular SKUs to satisfy clean-label certification requirements (NSF, USP, Informed Sport).
Industrial adoption of supercritical CO₂ extraction and membrane separation technologies has dramatically improved the purity and bioavailability of marigold lutein. Manufacturers can now achieve >90% free lutein concentrations with minimal solvent residues, meeting the strictest EU and FDA dietary supplement standards. Nano-emulsification and liposomal encapsulation are further enhancing the oral bioavailability of carotenoids — a historical limitation now largely overcome.
Regulatory agencies in the EU (EFSA), US (FDA GRAS status for lutein), and China (NMPA functional food approvals) have progressively recognized lutein and marigold-derived compounds in health claims related to antioxidant defense and cellular protection. Ongoing Phase II/III clinical trials investigating lutein's role in reducing MACE (major adverse cardiovascular events) are expected to further legitimize cardiovascular health claims, opening premium market segments currently dominated by omega-3s and CoQ10.
Leading extract manufacturers are investing in backward vertical integration — establishing contracted marigold cultivation farms (primarily in India, China, and Peru) to secure consistent raw material quality and traceability. This farm-to-capsule model satisfies the growing demand for supply chain transparency, a critical purchasing criterion for European and North American supplement brands. Blockchain-based traceability systems are being piloted by forward-thinking suppliers to provide real-time batch verification.
The B2B supply landscape is consolidating around a smaller number of vertically integrated, multi-certified suppliers. Brands are forming long-term exclusive ingredient partnerships to differentiate their cardiovascular supplement lines. Simultaneously, the white-label/private-label segment is booming — e-commerce health brands and direct-to-consumer (DTC) companies are sourcing standardized marigold extract at scale to launch heart-health product lines without in-house R&D infrastructure.
Marigold extract's versatile bioactivity enables integration across a spectrum of cardiovascular supplement formats and functional categories.
Oil-dispersed marigold lutein esters are ideal for softgel delivery, maximizing fat-soluble carotenoid absorption. Standardized to 5–20% lutein, these are co-formulated with omega-3 DHA/EPA, CoQ10, and vitamin K2 for comprehensive cardiovascular protection stacks targeting the premium supplement market.
Water-dispersible marigold extract (via spray-drying with maltodextrin or cyclodextrin encapsulation) enables fortification of heart-health beverages, protein bars, and dairy alternatives. Brands like heart-focused RTD drinks are incorporating 6–10 mg lutein per serving to meet the growing "food as medicine" consumer demand.
Marigold extract is increasingly featured in multi-ingredient cardiovascular formulas alongside hawthorn berry extract, berberine, nattokinase, and magnesium glycinate. These synergistic stacks address multiple CVD risk factors simultaneously — lipid management, blood pressure regulation, platelet aggregation, and endothelial health — commanding premium price points of $45–$90 per unit in the US market.
Given lutein's established role in macular health, marigold extract bridges cardiovascular and eye health — two of the top three supplement categories by consumer spending. Dual-benefit products targeting adults 45+ (a demographic with high CVD and AMD risk) represent a high-growth niche, with clinical positioning supported by the AREDS2 trial data and emerging cardiovascular carotenoid research.
Pharmaceutical companies are developing prescription-strength nutraceuticals ("nutraceutical 2.0") using highly purified marigold lutein (>90% free lutein) with clinically validated dosing protocols. These products, positioned between OTC supplements and prescription drugs, target patients with subclinical atherosclerosis or post-cardiac event recovery, representing a high-margin, medically supervised market segment.
AI-driven personalized nutrition platforms are incorporating marigold extract recommendations based on individual cardiovascular biomarker profiles (CRP, LDL, IMT scores). Subscription-based DTC brands now offer customized cardiovascular supplement packets where marigold lutein dosage is algorithmically adjusted to the user's blood test results — representing the frontier of precision nutraceutical delivery.
Every batch of our marigold extract and cardiovascular supplement ingredients undergoes rigorous multi-stage laboratory validation — ensuring efficacy, safety, and regulatory compliance.
This is the core test ensuring our marigold extract and related cardiovascular botanicals deliver their intended biological effect at the labeled potency.
Method: Primarily High-Performance Liquid Chromatography (HPLC) and Gas Chromatography (GC).
Key Parameters: HPLC system with Diode Array Detector (DAD) or UV-Vis Detector · C18 reverse-phase column (250 mm × 4.6 mm, 5 μm) · Mobile Phase: methanol-water or acetonitrile-water systems with pH adjustment · Flow Rate: 0.8–1.2 mL/min · Column Temperature: 30–40°C · Detection Wavelength set to target compound maximum absorption (e.g., 445 nm for lutein/zeaxanthin; 280 nm for EGCG in Green Tea Extract).
Objective: Ensure marker compound content (e.g., Lutein ≥80%, Ginsenosides, Pomegranate Ellagic Acid, Soy Isoflavones) meets specification — e.g., ≥98% or standardized ranges of 40%–50%.
Comprehensive safety testing is non-negotiable for cardiovascular supplement ingredients intended for daily long-term consumption.
Heavy Metals (AAS / ICP-MS): Lead (Pb) ≤ 5 mg/kg · Cadmium (Cd) ≤ 0.5 mg/kg · Arsenic (As) & Mercury (Hg) per pharmacopoeial limits (Chinese Pharmacopoeia General Chapter 0821).
Pesticide Residues (GC-MS/MS & LC-MS/MS): Screens 300+ pesticide residues per EU EC 396/2005 at ppb levels — critical for marigold sourced from conventional farms.
Microbial Limits: Total Aerobic Microbial Count ≤ 1,000 CFU/g · Yeasts & Moulds ≤ 100 CFU/g · E. coli: Absent in 1g · Salmonella: Absent in 10g.
Physical-chemical parameters define the manufacturability and shelf-life of marigold extract in cardiovascular supplement production.
Moisture Content (Karl Fischer Titration / Loss on Drying): Typically ≤ 5.0% — critical for preventing carotenoid degradation in storage.
Ash Content (Muffle Furnace): Total Ash & Acid-Insoluble Ash — controls inorganic impurities; limits vary by botanical source.
Solvent Residues (Headspace GC): Per ICH guidelines — Ethanol residue ≤ 5,000 ppm (0.5%); hexane ≤ 290 ppm for solvent-extracted lutein.
Particle Size Distribution (Laser Analyzer): D50, D90 controlled per client spec — e.g., 100% through 80 mesh for capsule filling compatibility.
Chromatographic Fingerprint Analysis: Establishes a characteristic "chemical fingerprint" using HPLC or GC for overall quality control and batch-to-batch consistency evaluation of complex extracts like marigold. This is particularly critical for cardiovascular supplement manufacturers requiring lot-to-lot reproducibility for clinical studies and regulatory submissions.
Stability Studies: ICH-compliant accelerated stability testing (40°C/75% RH for 6 months) ensures lutein and zeaxanthin potency retention throughout the product's stated shelf life — typically 24–36 months.
Through these systematic testing protocols, our laboratory builds a robust technical barrier ensuring every batch of marigold extract and cardiovascular supplement ingredient meets the stringent requirements of international regulations and our clients' quality standards.
The Testing Laboratory in our plant extract facility serves as the "heart" and "judicial department" of our cardiovascular ingredient manufacturing operation. It is the core technical unit responsible for ensuring product safety, efficacy, consistency, and compliance across our entire marigold extract and botanical supplement ingredient portfolio.
Operating independently from the production department, it exercises quality oversight and authority, providing scientific and objective data support for every step — from raw marigold petal intake to finished standardized extract release.
Our modern laboratory is constructed according to GMP (Good Manufacturing Practice) and CNAS (China National Accreditation Service for Conformity Assessment) standards. It is divided into functional areas including: Physicochemical Testing Area, Instrumental Analysis Area, Microbiological Testing Area, and Sample Preparation & Retention Area.
The lab is equipped with advanced precision instruments including HPLC-DAD, ICP-MS, GC-MS/MS, LC-MS/MS, Karl Fischer Titrators, Laser Particle Size Analyzers, and Muffle Furnaces. Our professional team holds backgrounds in analytical chemistry, pharmaceutics, and biology — collectively ensuring that every batch of cardiovascular supplement ingredient we supply meets the highest global standards.
Explore our full portfolio of standardized plant extracts — each rigorously tested and optimized for cardiovascular health supplement formulations.
Whether you're formulating a new cardiovascular supplement line or scaling an existing product, our GMP-certified marigold extract and botanical ingredient portfolio delivers the quality, consistency, and traceability your brand demands.
Request a Sample or Quote →